...
机译:ERK抑制剂LY3214996针对ERK途径驱动的癌症:精密药物的治疗方法
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
Eli Lilly &
Co Lilly Res Labs Indianapolis IN 46285 USA;
机译:ERK抑制剂LY3214996针对ERK途径驱动的癌症:精密药物的治疗方法
机译:自组装/药物组成的纳米药物,通过抑制ERK,AKT和STAT3信号传导级联,用于协同光子热疗和乳腺癌的靶向治疗。
机译:针对癌症治疗剂的纳米胺:对克服耐药性的精确药物
机译:使用CancerKB和KBCommons信息学框架实现精密医学
机译:精密药物的时代:使用基于转录组学的数学建模,靶癌治疗诱导心脏毒性的个体特异性预测
机译:新型柔顺性抑制剂可用于靶向天真的和耐药性刺猬途径驱动的癌症
机译:ERK抑制剂LY3214996针对ERK途径驱动的癌症:精密药物的治疗方法
机译:新型治疗靶点抑制肿瘤微环境诱导去势抵抗前列腺癌。